Table 1.

Summary of clinical guidance statements.

1. Follow-up PSG or HSAT is not recommended for routine reassessment of asymptomatic patients with obstructive sleep apnea on PAP therapy, however, follow-up PSG or HSAT can be used to reassess patients with recurrent or persistent symptoms, despite good PAP adherence.

2. Follow-up PSG or HSAT is recommended to assess response to treatment with non-PAP interventions.

3. Follow-up PSG or HSAT may be used if clinically significant weight gain or loss has occurred since diagnosis of OSA or initiation of treatment.

4. Follow-up PSG may be used for reassessment of sleep-related hypoxemia and/or sleep-related hypoventilation following initiation of treatment for OSA.

5. Follow-up PSG or HSAT may be used in patients being treated for OSA who develop or have a change in cardiovascular disease.

6. Follow-up PSG may be used in patients with unexplained PAP device-generated data.

HSAT = home sleep apnea test, OSA = obstructive sleep apnea, PAP = positive airway pressure, PSG = polysomnography.